Dr Dave Ousterout
Dave Ousterout is a co-founder and Chief Scientific Officer for Locus Biosciences. Dave holds a PhD from Duke University where he developed novel gene editing approaches for correcting mutations that cause Duchenne muscular dystrophy. His expertise is in protein engineering and early stage applications of new technologies to treat human diseases. At Locus, Dave is responsible for development of Locus’s crPhage platform and early stage product development. Prior to Locus, Dave was a consultant at McKinsey & Company.
Dr Rashid Chotani
Dr Erin Duffy
Dr Jon Iredell
Dr Paul Turner
Dr Danish Malik
Dr Carrie-Lynn Langlais Furr
Dr Gina Suh
Frenk Smrekar
Dr Steven Theriault
Dr. Steven Theriault is a passionate scientist with 20 years of research and entrepreneurial experience in generating biological solutions for biological problems. He founded Cytophage Technologies Inc., a company that uses natural, modified and synthetic bacteriophages to create a diversity of products that combat bacterial infections affecting human health, animal health and food security. Dr. Theriault’s goal is to enable bacteriophages to become mainstream for treating human and animal bacterial infections, thereby averting the WHO’s predicted AMR crisis and avoiding needless suffering.